1例肝门部胆管占位患者ERCP术后感染脑膜脓毒性伊丽莎白金菌合并植生拉乌尔菌的药学监护

Pharmaceutical Care for a Patient with Hilar Bile Duct Space Occupying after ERCP Infected by Elizabethkingia Meningoseptica and Raoule Planticola

1例肝门部胆管占位患者经内镜逆行胰胆管造影(ERCP)术后发生感染,其胆汁及血液中先后培养出脑膜脓毒性伊丽莎白金菌和植生拉乌尔菌临床罕见病原体。临床药师参与该患者抗感染治疗,从经验性治疗到针对性治疗进行分析,探讨总结对于该类患者非典型病原体感染后的治疗方法和药物选择,回顾总结治疗过程中需改进提升的地方,为今后类似病例治疗提供参考。通过临床药师的参与更加保证了患者用药安全性和有效性,也体现临床药师在临床少见病原体感染患者治疗中可发挥的作用,同时临床药师通过参与患者治疗及药学监护,不断提升自身的业务能力,进而更好地服务临床。

A patient with hilar bile duct space occupying developing infection after ERCP.The bile and blood of the patient were successively cultured,and found clinical rare pathogens Elizabethkingia meningoseptica and Raoulia plantarum.This article took clinical pharmacists participating in the anti-infective treatment of this patient as an example,analyzed from empirical treatment to targeted treatment,and discussed and summarized the treatment methods for such atypical pathogens and the areas that needed to be improved in the treatment of such patients,so as to provide reference for the treatment of similar cases.The participation of clinical pharmacists further ensures the safety and effectiveness of medication for patients,and also reflects the role that clinical pharmacists can play in the treatment of patients infected by rare pathogens in order to provide clinical services better.